MiR-23a Functions as a Tumor Suppressor in Osteosarcoma
Author(s) -
Yu He,
Chunqing Meng,
Zengwu Shao,
Hong Wang,
Shuhua Yang
Publication year - 2014
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000366353
Subject(s) - osteosarcoma , ectopic expression , cell growth , cancer research , microrna , biology , dna methylation , runx2 , reporter gene , in vivo , luciferase , transfection , microbiology and biotechnology , transcription factor , cell culture , gene expression , gene , genetics
Osteosarcoma is the most common primary bone malignancy in children and adolescents, and the pathogenesis of this cancer remains unclear. Therefore, the discovery of new biomarkers for the diagnosis, prognosis, and treatment of osteosarcoma remains an important but unmet clinical need.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom